VentriPoint Diagnostics Ltd.
VentriPoint Diagnostics Ltd. (VPTDF) Stock Overview
Explore VentriPoint Diagnostics Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.1M
P/E Ratio
-4.28
EPS (TTM)
$-0.02
ROE
1.07%
VPTDF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of VentriPoint Diagnostics Ltd. (VPTDF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 37.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.04.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.28 and a market capitalization of 13.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.